**1. Alzheimer's Epidemiology**

Alzheimer's disease (AD) is a progressive neurological disorder that accounts for the greatest number of dementia cases. As of 2019, 5.8 million people were living with AD, with its prevalence predicted to increase to 13.8 million by 2050 [1]. The vast majority of cases are concentrated in ages over 65, impacting 10% of people in this age group. In addition, the economic toll of AD on the United States economy is significant, estimated to be roughly USD 290 billion in 2019 [1]. As the number of cases is only expected to rise over the coming decades, research in this field is critical in order to understand the pathology of this disease, as well as potential therapeutics.
